My Locations
Part of the Duke Cancer Institute
About Me
I am a radiation oncologist, and I primarily focus on treating patients with cancer of the brain, lung, and spine. I find great satisfaction meeting with patients and working to provide the best care possible. During our visits, I enjoy getting to know patients and their families and learning about their hobbies, interests, and values. Working together, my goal is provide the tools and understanding so that they feel comfortable in making treatment decisions. I have the privilege of being a part of an excellent team of doctors, nurses, therapists, and treatment planners, who all work to design and carry out a personalized treatment plan for each patient. Outside of the clinic, I enjoy spending time with my family and friends.
- Assistant Professor of Radiation Oncology, Radiation Oncology 2024
- Member of the Duke Cancer Institute, Duke Cancer Institute 2022
Call for an Appointment
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
Clinical Focus and Research
- Phase 2 Randomized Clinical Trial Comparing the Safety and Efficacy of PULSAR-Integrated Radiotherapy + Pembrolizumab or Nivolumab Administered with or without STING-Agonist IMSA101 in Patients with Oligometastatic Non-Small Cell Lung Cancer and Rena awarded by ImmuneSensor Therapeutics, Inc. 2024 - 2024
- Vaios, Eugene J., Rachel F. Shenker, Peter G. Hendrickson, Zihan Wan, Donna Niedzwiecki, David Carpenter, Warren Floyd, et al. “Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases.” JAMA Netw Open 8, no. 4 (April 1, 2025): e254347. https://doi.org/10.1001/jamanetworkopen.2025.4347.
- Yang, Zhenyu, Mercedeh Khazaieli, Eugene Vaios, Rihui Zhang, Jingtong Zhao, Trey Mullikin, Albert Yang, Fang-Fang Yin, and Chunhao Wang. “Total brain dose estimation in single-isocenter-multiple-targets (SIMT) radiosurgery via a novel deep neural network with spherical convolutions.” Med Phys, March 18, 2025. https://doi.org/10.1002/mp.17748.
- Leng, Jim X., David J. Carpenter, Christina Huang, Jamiluddin Qazi, Muzamil Arshad, Trey C. Mullikin, Zachary J. Reitman, et al. “Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course.” Adv Radiat Oncol 9, no. 6 (June 2024): 101475. https://doi.org/10.1016/j.adro.2024.101475.
- Mullikin, T. C., J. Tanksley, J. K. Salama, and J. P. Kirkpatrick. “Rationale for Fractionated and Single-Session Approaches.” In Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: A Comprehensive Guide: Second Edition, 31–41, 2024. https://doi.org/10.1007/978-3-031-67743-4_3.
- Boyer, M., T. Mullikin, C. Wilke, C. L. Cho, and P. W. Sperduto. “Patient Selection.” In Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: A Comprehensive Guide: Second Edition, 361–76, 2024. https://doi.org/10.1007/978-3-031-67743-4_28.
- Kowalchuk, Roman O., Trey C. Mullikin, Grant M. Spears, Benjamin A. Johnson-Tesch, Peter S. Rose, Brittany L. Siontis, Dong Kun Kim, et al. “Assessment of minimum target dose as a predictor of local failure after spine SBRT.” In Radiother Oncol, 195:110260, 2024. https://doi.org/10.1016/j.radonc.2024.110260.
- Kowalchuk, R., T. C. Mullikin, W. Breen, H. C. Gits, M. Florez, B. De, W. S. Harmsen, et al. “Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy.” In Frontiers in Oncology, Vol. 13, 2023. https://doi.org/10.3389/fonc.2023.1095170.
- Kowalchuk, Roman O., Benjamin A. Johnson-Tesch, Joseph T. Marion, Trey C. Mullikin, William S. Harmsen, Peter S. Rose, Brittany L. Siontis, et al. “Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases.” In JAMA Oncol, 8:412–19, 2022. https://doi.org/10.1001/jamaoncol.2021.7008.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- Duke Cancer Network
- Telix Pharmaceuticals Limited